Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Pronzato

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Oncology|April 28, 2005
Standard of care for cancer-related anemia: improving hemoglobin levels and quality of lifeEnrico Cortesi, Pere Gascón, David Henry, et al.
Critical Reviews in Oncology/Hematology|July 9, 2008
Targeting the VEGF pathway: antiangiogenic strategies in the treatment of non-small cell lung cancerMarianna Aita, Gianpiero Fasola, Carlotta Defferrari, et al.
Expert Opinion on Biological Therapy|April 18, 2012
Ipilimumab (MDX-010) in the treatment of non-small cell lung cancerCarlo Genova, Erika Rijavec, Giulia Barletta, et al.
Frontiers in Immunology|January 24, 2022
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint BlockadeCarlo Genova, Chiara Dellepiane, Paolo Carrega, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 24, 2013
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza studyCarlo Lazzaro, Roberto Bordonaro, Francesco Cognetti, et al.
Immunotherapy|February 25, 2021
Safety and efficacy of immune checkpoint inhibitors in non-small-cell lung cancer: focus on challenging populationsLodovica Zullo, Giovanni Rossi, Chiara Dellepiane, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2021
Health-related quality of life in cancer patients treated with immune checkpoint inhibitors in randomised controlled trials: A systematic review and meta-analysisAndrea Boutros, Marco Bruzzone, Enrica T Tanda, et al.
Journal of Genetic Counseling|August 29, 2022
Experience with a nurse-driven genetic counseling pathway of Italian women with uninformative BRCA test resultEva Blondeaux, Matteo Lambertini, Giulia Buzzatti, et al.
Tumori|April 27, 2005
Epirubicin and gemcitabine as first-line treatment in malignant pleural mesotheliomaLuigi Portalone, Antonio Antilli, Francesco Nunziati, et al.
Dermatology Practical & Conceptual|February 16, 2024
Diffuse Melanosis Cutis as the First Sign of Recurrence of Low-Risk Melanoma: Case Report and Systematic ReviewAnna Graziella Burroni, Niccolò Capurro, Franco Rongioletti, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Oncology|April 28, 2005
Standard of care for cancer-related anemia: improving hemoglobin levels and quality of lifeEnrico Cortesi, Pere Gascón, David Henry, et al.
Critical Reviews in Oncology/Hematology|July 9, 2008
Targeting the VEGF pathway: antiangiogenic strategies in the treatment of non-small cell lung cancerMarianna Aita, Gianpiero Fasola, Carlotta Defferrari, et al.
Expert Opinion on Biological Therapy|April 18, 2012
Ipilimumab (MDX-010) in the treatment of non-small cell lung cancerCarlo Genova, Erika Rijavec, Giulia Barletta, et al.
Frontiers in Immunology|January 24, 2022
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint BlockadeCarlo Genova, Chiara Dellepiane, Paolo Carrega, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 24, 2013
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza studyCarlo Lazzaro, Roberto Bordonaro, Francesco Cognetti, et al.
Immunotherapy|February 25, 2021
Safety and efficacy of immune checkpoint inhibitors in non-small-cell lung cancer: focus on challenging populationsLodovica Zullo, Giovanni Rossi, Chiara Dellepiane, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2021
Health-related quality of life in cancer patients treated with immune checkpoint inhibitors in randomised controlled trials: A systematic review and meta-analysisAndrea Boutros, Marco Bruzzone, Enrica T Tanda, et al.
Journal of Genetic Counseling|August 29, 2022
Experience with a nurse-driven genetic counseling pathway of Italian women with uninformative BRCA test resultEva Blondeaux, Matteo Lambertini, Giulia Buzzatti, et al.
Tumori|April 27, 2005
Epirubicin and gemcitabine as first-line treatment in malignant pleural mesotheliomaLuigi Portalone, Antonio Antilli, Francesco Nunziati, et al.
Dermatology Practical & Conceptual|February 16, 2024
Diffuse Melanosis Cutis as the First Sign of Recurrence of Low-Risk Melanoma: Case Report and Systematic ReviewAnna Graziella Burroni, Niccolò Capurro, Franco Rongioletti, et al.
Pageof 10